Obvious Ventures — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
BiotechSalt Lake City, US
Blake C. Borgeson(Executive Officer, Director)Christopher C. Gibson(Executive Officer, Director)Christopher C Gibson(Executive Officer)Dean Y. Yi(Executive Officer, Director)
Co-investorsAmplify PartnersManta Ray VenturesCRV (Charles River Ventures)DCVC (Data Collective)Lux CapitalMenlo Ventures
Burlingame, US
Lily Kanter(Executive Officer, Director)Jill A. Horn(Executive Officer, Director)
BoardMarshall Milliken(Director)
Board seatVishal Vasishth· per SEC Form D · $7.1M raise · filed Sep 2018
Pegasus Solar designs and manufactures rooftop solar mounting systems and installation hardware for solar installers.
CleantechConstruction TechEnergyHardwareSaaSSan Jose, US
Kai Stephan(Founder)Erich Kai Stephan(Executive Officer, Director)
BoardMark Conroy(Director)B. Marc Averitt(Director)
Board seatMike Miskovsky· per SEC Form D · $8.6M raise · filed Sep 2017
Co-investorsEcosystem Integrity Fund
Devoted Health offers Medicare Advantage plans and integrated healthcare services for older Americans, including virtual and in-home care, member support guides, and coordination with local providers across 29 states.
HealthtechInsurTechUnited States, US
Todd Park(Co-founder)inEdward Park(Executive Officer, Director)Ed Park(Co-founder)in
BoardBryan Roberts(Director)inRobert Kocher(Director)inWilliam Frist(Director)
PartnerVishal Vasishth· led
Co-investorsAndreessen HorowitzBronze InvestmentsCapital FactoryDns CapitalDreamers VCF-Prime Capital+18 more
LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.
AI & Machine LearningBiotechDeep TechLondon
Harrison Rickerby(Executive Officer, Director)
BoardJames Field(Executive Officer, Director)in
Co-investorsAcequia Capital (AceCap)Air Street CapitalBackedBeast VenturesChampion Hill VenturesGigafund+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.